IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
MRNA News
Archived Headlines
- Is the IPO market the pathway out of the forest? 04/23/20
- US IPO Weekly Recap: Two billion-dollar biotechs cap a mixed week for biotech IPOs 02/08/19
- Renaissance Capital's Updated 2018 US IPO Annual Review 01/04/19
- US IPO Weekly Recap: Biggest biotech breaks in 3-IPO week 12/07/18
- Moderna prices upsized IPO at $23 midpoint; largest biotech IPO ever 12/06/18
See more
Biotech IPOs close to beating Covid-19
Less than nine months after Covid-19 became an unwelcome household word, the virus may be close to being vanquished. A number of biotech IPOs are key players in vaccine development. Most prominent is headline grabber Moderna (MRNA), which went public in December 2018. However, BioNTech (BNTX), an October 2019 IPO, and Pfizer may be first to get FDA approval. Vir...read more
IPO Index touches all-time high, fueled by #4 holding Moderna
The Renaissance IPO Index rose 2.8% on Monday, and surpassed its all-time high in mid-day trading. The IPO Index is now up 12.9% for the year, outperforming the S&P 500 by 20 points, and the Nasdaq Composite by 10 points. The Renaissance IPO ETF (NYSE: IPO) tracks the...read more
Llamas vs. Bats: Llama antibodies, the coronavirus, and the biotechs that benefit
Could llamas be the key to containing the coronavirus? Scientists from several institutions have developed a treatment using antibodies found in llamas, called single-domain antibodies, to fight SARS-CoV-2 (Covid-19), a strain naturally found in bats.read more
The 2020 IPO market is now up 43% from its lows, a promising sign for May
IPOs are leading the stock market's recovery. The Renaissance IPO Index has soared 42.6% from its mid-March low, compared to a 28.9% rebound for the S&P 500. The IPO Index, which is composed of the largest and most liquid IPOs over the past two years and tracked by the IPO ETF (NYSE: IPO), closed Monday...read more